Morning Immunotherapy Doubles Advanced Lung Cancer Survival Rates, Macron Maintains Cancer Fight Budget
New research shows morning immunotherapy doubles survival in advanced lung cancer, while Macron maintains consistent cancer budget through 2030 with focus on screenings and prevention.